对乙型肝炎表面抗原随时间的下降进行基于组的轨迹建模,可以准确地识别慢性乙型肝炎患者实现功能治愈:中国的一项单中心队列研究
Yuchen Peng1, Liping Liu2, Xiaoping Wu1
1Department of Infectious Diseases, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Annals of medicine
|March 11, 2026
概括
一个新的模型预测哪些慢性乙型肝炎 (CHB) 患者将通过基化干扰素α (PEG-IFNα) 实现功能治愈. 这个工具有助于个性化治疗策略的CHB患者,旨在乙型肝炎表面抗原 (HBsAg) 血清清除.
科学领域:
- 肝病学和病毒性肝炎研究研究
- 生物统计学和预测建模
- 个性化医学在传染病中的应用
背景情况:
- 确定可能达到乙型肝炎表面抗原 (HBsAg) 血清清除的患者对于优化慢性乙型肝炎 (CHB) 治疗策略至关重要.
- 基化干扰素α (PEG-IFNα) 是治疗心脏病的一种治疗方法,预测其疗效可能会导致一个可靠的治疗方法.
- 功能性治疗 治疗 治疗
- . . . . . . . . . . . . . . 这是一个很好的时刻.
研究的目的:
- 开发一个基于组的轨迹模型 (GBTM) 来预测用PEG-IFNα治疗的CHB患者的HBsAg血清清除.
- 在CHB管理中创建个性化治疗策略的预测工具.
主要方法:
- 使用342名接受PEG-IFNα治疗的CHB患者的基线数据开发了一个基于组的轨迹模型 (GBTM).
- 该模型确定了HBsAg随着时间的推移而下降的三个不同的轨迹组.
- 使用接收机操作特征 (ROC) 曲线,校准曲线和决策曲线分析 (DCA) 验证了模型准确性.
主要成果:
- 38.30%的患者实现了功能治愈 (HBsAg血清清除).
- GBTM确定了三个轨迹组 (快速,中度,缓慢的HBsAg下降),缓慢下降组显示出更高的病毒载量和肝功能受损.
- 基于GBTM的模型在训练,验证和测试数据集中显示出高准确性 (AUC>0.920) 和临床实用性.
结论:
- 基于GBTM的3组轨迹模型准确地识别了可能通过PEG-IFNα治疗实现功能治愈的CHB患者.
- 这种预测模型是开发个性化治疗策略的宝贵工具,以优化CHB的功能治愈率.
相关概念视频
Retrovirus Life Cycles
50.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
247
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
247
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
366
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
366
Kaplan-Meier Approach
679
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
679


